Pharmaceutical
The following technologies are available for licensing in this group:
Technology Updates
In order to keep in touch with people and organisations interested in Isis' technologies, we provide regular email updates on new technologies. Request Technology Updates.
Chiral Peptide Nucleic Acids (Isis-66)
Controlled Drug Release (Isis-957)
Improved Vaccination Using Lentivirus in Prime/Boost Protocols (Isis-1428)
Comprehensive Meningococcal Vaccine (Isis-1538)
Recombinant Overlapping Peptide Vaccines for Infectious Disease and Cancer (Isis-2452)
Transfection Reagent Adjuvant (Isis-2791)
Allergen Specific T-cell Clones for Antibody testing (Isis-2816)
Molecular Shape Recognition (Isis-2932)
A Novel Cancer Biomarker and Drug Target (Isis-3101)
Adenovirus: Vector Improvements (Isis-3266)
High Density Protein Nanoarray (Isis-3310)
High-Throughput Screening Of Membrane Proteins (Isis-3329)
MVA NP + M1 Influenza Vaccine (Isis-3360)
AdCh63 ME.TRAP Malaria Vaccine (Isis-3479)
Novel Vaccine Ajuvants-CCR4 Antagonists (Isis-3491)
Oxford Genome-wide Association Software Suite (Isis-3507)
Biomarker For Improving Statin Therapy (Isis-3542)
Improved Drug Target Characterisation and Screening (Isis-3579)
RNA interference (RNAi) Technology (Isis-3581)
A Novel Method For The Treatment Of Obesity (Isis-3593)
Novel Method for Enhancing Protein Yields in the Lab and in Large Scale Manufacture (Isis-3776)
Prime/Boost Vaccination using a Mixed Vector Approach (Isis-3991)
Improving Drug Research and Development (Isis-4089)
Novel RNAi Delivery Technology (Isis-4096)
Software for Cancer Prognosis (Isis-4142)
Ultra-Stable Streptavidin (Isis-4258)
Antigen Identification (Isis-4377)
Nucleic Acid Adaptor Technology (Isis-6629)
Bipolar Disorder Drug Candidate (Isis-6897)
Neurological Phase II Opportunity (Isis-7163)
Analysing the Neurobiology of Learning and Memory (Isis-7851)
Regular email updates on new technologies
Technologies